Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Characteristics of patients who received deep brain stimulation in obsessive-compulsive disorder versus major depressive disorder.

Authors:
Nagy A Youssef Phung Phung Rikinkumar S Patel

J Psychiatr Res 2021 Apr 16;136:384-387. Epub 2021 Feb 16.

Department of Psychiatry, Griffin Memorial Hospital, 900 E Main St, Norman, OK, 73071, USA; Department of Psychiatry and Behavioral Science, Oklahoma State University, 1111 W 17th St, Tulsa, OK, 74107, USA. Electronic address:

Objective: Deep brain stimulation (DBS) is cleared for treatment of obsessive-compulsive disorder (OCD) but is an investigational treatment for major depressive disorder (MDD). The aim of this study is to compare the characteristics of patients who received DBS as part of standard care for OCD versus those who received it a part of a research protocol for MDD.

Methods: The inpatient sample (N = 110) was drawn from the 2012-2014 Nationwide Inpatient Sample (NIS), and included adults with a primary discharge diagnosis of MDD (N = 50) or OCD (N = 60) and primary procedure of DBS. The study compared various patient demographics, clinical, hospital and insurance variables between the 2 groups.

Results: DBS recipients with OCD were younger compared to those with MDD. DBS recipients with MDD tended to be from high-income families compared to those with OCD. DBS patients with MDD were in the South region, while DBS patients with OCD were in the Midwest and South regions of the United States (US). The study did not detect a significant difference in the length of stay and total charges among DBS recipients with OCD versus MDD.

Conclusions: DBS patients with MDD are typically older with more financial resources compared to those with OCD. DBS is federally cleared for OCD, but not for MDD, demonstrating the need for further investigation to establish DBS as a federally cleared treatment for difficult to treat MDD if well-powered randomized trials further support its use.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpsychires.2021.02.032DOI Listing
April 2021

Publication Analysis

Top Keywords

dbs recipients
12
dbs patients
12
dbs
11
ocd
9
obsessive-compulsive disorder
8
dbs federally
8
mdd
8
federally cleared
8
major depressive
8
inpatient sample
8
depressive disorder
8
recipients ocd
8
ocd versus
8
patients mdd
8
patients received
8
compared ocd
8
deep brain
8
brain stimulation
8
ocd dbs
8
characteristics patients
8

Keyword Occurance

Similar Publications

Characteristics of patients who received deep brain stimulation in obsessive-compulsive disorder versus major depressive disorder.

Authors:
Nagy A Youssef Phung Phung Rikinkumar S Patel

J Psychiatr Res 2021 Apr 16;136:384-387. Epub 2021 Feb 16.

Department of Psychiatry, Griffin Memorial Hospital, 900 E Main St, Norman, OK, 73071, USA; Department of Psychiatry and Behavioral Science, Oklahoma State University, 1111 W 17th St, Tulsa, OK, 74107, USA. Electronic address:

Objective: Deep brain stimulation (DBS) is cleared for treatment of obsessive-compulsive disorder (OCD) but is an investigational treatment for major depressive disorder (MDD). The aim of this study is to compare the characteristics of patients who received DBS as part of standard care for OCD versus those who received it a part of a research protocol for MDD.

Methods: The inpatient sample (N = 110) was drawn from the 2012-2014 Nationwide Inpatient Sample (NIS), and included adults with a primary discharge diagnosis of MDD (N = 50) or OCD (N = 60) and primary procedure of DBS. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Economic Impact of Schizophrenia from a Hospital and Social Security System Perspective in Italy.

Authors:
Francesco Saverio Mennini Andrea Marcellusi Simone Gazzillo Claudia Nardone Paolo Sciattella Raffaele Migliorini Marco Trabucco Aurilio Mario Amore Roberto Brugnoli

Clin Drug Investig 2021 Feb 9;41(2):183-191. Epub 2021 Feb 9.

Università degli Studi di ROMA "La Sapienza", Rome, Italy.

Background: Schizophrenia is one of the mental disorders with the highest economic and social costs, with an important burden on patients, caregivers, and society.

Objective: The objective of this study was to estimate the direct and social security costs of schizophrenia in Italy. As far as direct costs are concerned, those related to hospitalizations and pharmaceutical expenditure have been analyzed, while disability benefits (DBs) and incapacity pensions (IPs) have been considered for the social security costs. Read More

View Article and Full-Text PDF
February 2021
Similar Publications

Survival and Health Care Use After Deep Brain Stimulation for Parkinson's Disease.

Authors:
James A G Crispo Melody Lam Britney Le Salimah Z Shariff Dominique R Ansell Melanie Squarzolo Danielle Ouellette Dylan P Thibault Connie Marras Allison W Willis Dallas Seitz

Can J Neurol Sci 2020 Aug 28:1-11. Epub 2020 Aug 28.

Department of Psychiatry, Queen's University, ICES-Queen's, Kingston, ON, Canada.

Objectives: To compare long-term survival of Parkinson's disease (PD) patients with deep brain stimulation (DBS) to matched controls, and examine whether DBS was associated with differences in injurious falls, long-term care, and home care.

Methods: Using administrative health data (Ontario, Canada), we examined DBS outcomes within a cohort of individuals diagnosed with PD between 1997 and 2012. Patients receiving DBS were matched with non-DBS controls by age, sex, PD diagnosis date, time with PD, and a propensity score. Read More

View Article and Full-Text PDF
August 2020
Similar Publications

Assessment of disease specific immune responses in enteric diseases using dried blood spot (DBS).

Authors:
Md Saruar Bhuiyan Motaher Hossain Salma Sharmin Afsana Shirin Farhana Khanam Fahima Chowdhury Afroza Akter Ashraful Islam Khan Muhammad Ikhtear Uddin Taufiqur Rahman Bhuiyan Firdausi Qadri

PLoS One 2019 17;14(6):e0218353. Epub 2019 Jun 17.

icddr,b (International Centre for Diarrhoeal Disease Research, Bangladesh), Dhaka, Bangladesh.

Background: Blood collection, transportation and storage remain a problem in countries where infrastructure, laboratory facilities and skilled manpower are scarce. This limits evaluation of immune responses in natural infections and vaccination in field studies. We developed methods to measure antigen specific antibody responses using dried blood spot (DBS) in cholera, ETEC and typhoid fever patients as well as recipients of oral cholera vaccine (OCV). Read More

View Article and Full-Text PDF
February 2020
Similar Publications

Predictability of Capillary Blood Spot Toward Venous Whole Blood Sampling for Therapeutic Drug Monitoring of Tacrolimus in Solid Organ Transplant Recipients.

Authors:
Jaryd Gallant Jenny Wichart Tony K L Kiang

Eur J Drug Metab Pharmacokinet 2019 Dec;44(6):729-741

Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton,, AB, Canada.

Therapeutic drug monitoring (TDM) of tacrolimus in whole blood obtained from venipuncture is routinely practiced. Dried blood spotting (DBS) may act as a suitable alternative for tacrolimus TDM due to relative ease of sampling and processing. The objective of this literature review was to provide a critical evaluation on the feasibility (i. Read More

View Article and Full-Text PDF
December 2019
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap